Average Co-Inventor Count = 3.99
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (37 from 2,285 patents)
37 patents:
1. 9637467 - Treatment of inflammatory bowel disease
2. 9427401 - Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
3. 9156810 - Treatment of inflammatory bowel disease
4. 9120784 - 1,3,4-oxadiazoles-2-thio azetidine derivatives as sphingosine-1 phosphate receptors modulators
5. 9024042 - Reduced central corneal thickening by use of hydrophilic ester prodrugs of beta-chlorocyclopentanes
6. 9000016 - 1,3,4-Oxadiazoles-2-thio derivatives as sphingosine-1 phosphate receptors modulators
7. 8993553 - Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
8. 8957051 - Bicyclic 1, 2, 4-oxadiazoles derivatives as sphingosine-1 phosphate receptors modulators
9. 8906899 - Azetidine derivatives as sphingosine 1-phosphate (S1P) receptor modulators
10. 8859598 - 1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
11. 8846729 - 2-thio-1,3,4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
12. 8846728 - Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators
13. 8754122 - Geminal dialkyl prostanoids
14. 8754066 - Phenoxy derivatives as sphingosine 1-phosphate (S1P) receptor modulators
15. 8735433 - Aryl oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators